ViaDerma, Inc. (VDRM)

ViaDerma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2017	FY 2016	FY 2015	FY 2011	FY 2010
Period Ending	Feb 13, 2026	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2011	Dec 31, 2010
Market Capitalization	0	6	1	0	1	8
Market Cap Growth	-94.33%	919.84%	160496.88%	-99.97%	-81.82%	-81.67%
Enterprise Value	-	12	7	6	10	11
Last Close Price	0.00	0.01	0.00	0.00	10.00	55.00
PE Ratio	-	-	-	0.01	0.51	1.68
PS Ratio	11.04	141.10	2.45	0.00	0.07	0.28
PB Ratio	-0.47	-6.00	-2.16	0.00	0.04	0.26
P/TBV Ratio	-	-	-	-	0.04	0.26
P/FCF Ratio	-	-	-	-	-	11.61
P/OCF Ratio	-	-	-	-	0.23	0.97
EV/Sales Ratio	-	276.42	26.46	31.54	0.51	0.40
EV/EBITDA Ratio	-	-	51.91	63.86	1.40	1.16
EV/EBIT Ratio	-	-	52.31	64.52	2.38	1.39
EV/FCF Ratio	-	-	-	-	-	16.59
Debt / Equity Ratio	-0.40	-0.40	-1.07	-0.52	0.23	0.17
Debt / EBITDA Ratio	-	-	2.39	3.04	1.12	0.52
Debt / FCF Ratio	-	-	-	-	-	7.41
Net Debt / Equity Ratio	-0.39	-0.39	-1.03	-0.52	0.21	0.13
Net Debt / EBITDA Ratio	-0.69	-0.69	2.31	3.04	1.04	0.41
Net Debt / FCF Ratio	-2.45	-2.45	-24.60	-25.76	-2.10	5.91
Asset Turnover	0.11	0.11	0.90	-	0.48	0.81
Inventory Turnover	0.60	0.60	17.90	-	35.22	53.97
Quick Ratio	0.27	0.27	0.57	0.23	2.44	2.50
Current Ratio	0.29	0.29	0.57	0.23	2.56	2.71
Return on Equity (ROE)	-	-	-	-	8.52%	17.12%
Return on Assets (ROA)	-91.23%	-91.23%	28.33%	-	6.41%	14.68%
Return on Invested Capital (ROIC)	-	-	-	0.46%	8.26%	18.22%
Return on Capital Employed (ROCE)	56.50%	56.50%	-44.40%	-16.90%	11.00%	25.70%
Earnings Yield	-307.69%	-24.08%	-19.70%	7044.42%	194.64%	59.67%
FCF Yield	-	-2.65%	-1.95%	-2906.23%	-245.98%	8.61%
Buyback Yield / Dilution	-273883.32%	-133.98%	-55.10%	-75400.79%	-	0.76%

Updated May 3, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.